[go: up one dir, main page]

NO177591C - Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler

Info

Publication number
NO177591C
NO177591C NO911200A NO911200A NO177591C NO 177591 C NO177591 C NO 177591C NO 911200 A NO911200 A NO 911200A NO 911200 A NO911200 A NO 911200A NO 177591 C NO177591 C NO 177591C
Authority
NO
Norway
Prior art keywords
therapeutically active
adenosine receptor
analogous process
selective adenosine
receptor agents
Prior art date
Application number
NO911200A
Other languages
English (en)
Other versions
NO911200L (no
NO177591B (no
NO911200D0 (no
Inventor
Norton Paul Peet
Nelson Lowell Lentz
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO911200D0 publication Critical patent/NO911200D0/no
Publication of NO911200L publication Critical patent/NO911200L/no
Publication of NO177591B publication Critical patent/NO177591B/no
Publication of NO177591C publication Critical patent/NO177591C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO911200A 1990-03-26 1991-03-25 Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler NO177591C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/499,111 US5047534A (en) 1990-03-26 1990-03-26 Selective adenosine receptor agents

Publications (4)

Publication Number Publication Date
NO911200D0 NO911200D0 (no) 1991-03-25
NO911200L NO911200L (no) 1991-09-27
NO177591B NO177591B (no) 1995-07-10
NO177591C true NO177591C (no) 1995-10-18

Family

ID=23983864

Family Applications (1)

Application Number Title Priority Date Filing Date
NO911200A NO177591C (no) 1990-03-26 1991-03-25 Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler

Country Status (22)

Country Link
US (1) US5047534A (no)
EP (1) EP0449175B1 (no)
JP (1) JP3181305B2 (no)
KR (1) KR100195368B1 (no)
CN (1) CN1032815C (no)
AR (1) AR247887A1 (no)
AT (1) ATE156130T1 (no)
AU (1) AU632914B2 (no)
CA (1) CA2038747C (no)
DE (1) DE69127010T2 (no)
DK (1) DK0449175T3 (no)
ES (1) ES2107431T3 (no)
FI (1) FI98461C (no)
GR (1) GR3025135T3 (no)
HU (1) HU208824B (no)
IE (1) IE910982A1 (no)
IL (1) IL97656A (no)
NO (1) NO177591C (no)
NZ (1) NZ237484A (no)
PH (1) PH27511A (no)
PT (1) PT97133B (no)
ZA (1) ZA912038B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208240A (en) * 1991-03-12 1993-05-04 Merrell Dow Pharmaceuticals Inc. 8-substituted purines as selective adenosine receptor agents
CA2116967C (en) * 1992-07-08 2003-08-19 Fumio Suzuki Antidepressants
ES2120025T3 (es) * 1993-02-26 1998-10-16 Merrell Pharma Inc Derivados de xantina utilizados como antagonistas de receptores de adenosina a1.
AU6781194A (en) * 1993-05-03 1994-11-21 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
WO1994026744A1 (en) * 1993-05-06 1994-11-24 Merrell Dow Pharmaceuticals Inc. 8-substituted xanthines as selective adenosine receptor agents
US5629298A (en) * 1995-03-13 1997-05-13 University Of Massachusetts Medical Center Adenosine as a positive inotrop in the compromised heart
GB9819382D0 (en) 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds I
US6258794B1 (en) 1999-12-14 2001-07-10 The Mclean Hospital Corporation Treatment of mental conditions including depression
ATE481101T1 (de) * 2003-06-10 2010-10-15 Kyowa Hakko Kirin Co Ltd Verfahren zur behandlung von angstzuständen
WO2007036491A1 (de) * 2005-09-30 2007-04-05 Basf Aktiengesellschaft Verfahren zur herstellung von alpha-substituierten carbonsäuren
US7592461B2 (en) * 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
KR102060903B1 (ko) * 2018-09-12 2019-12-30 김지훈 다중접합 도마 및 그 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435916A (en) * 1972-05-11 1976-05-19 Beecham Group Ltd Pharmaceutical weight-reducing compositions
SE416810C (sv) * 1977-10-14 1982-07-19 Draco Ab Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
JPS57198544A (en) * 1981-05-28 1982-12-06 Sony Corp Manufacture of magnetic recording medium
US4593095A (en) * 1983-02-18 1986-06-03 The Johns Hopkins University Xanthine derivatives
US4772607A (en) * 1986-05-20 1988-09-20 Warner-Lambert Company Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US4783530A (en) * 1986-11-13 1988-11-08 Marion Laboratories, Inc. 8-arylxanthines
DE8817122U1 (de) * 1988-12-22 1993-02-04 Boehringer Ingelheim Kg, 55218 Ingelheim Neue Xanthinderivate mit Adenosinantogenistischer Wirkung

Also Published As

Publication number Publication date
CA2038747A1 (en) 1991-09-27
IL97656A0 (en) 1992-06-21
KR100195368B1 (ko) 1999-06-15
ES2107431T3 (es) 1997-12-01
PT97133A (pt) 1991-12-31
NO911200L (no) 1991-09-27
CN1055181A (zh) 1991-10-09
FI911420A0 (fi) 1991-03-25
NO177591B (no) 1995-07-10
PH27511A (en) 1993-08-18
CN1032815C (zh) 1996-09-18
AU7353791A (en) 1991-10-03
AR247887A1 (es) 1995-04-28
PT97133B (pt) 1998-07-31
HU208824B (en) 1994-01-28
IE910982A1 (en) 1991-10-09
HUT56570A (en) 1991-09-30
EP0449175B1 (en) 1997-07-30
GR3025135T3 (en) 1998-02-27
EP0449175A2 (en) 1991-10-02
ATE156130T1 (de) 1997-08-15
JP3181305B2 (ja) 2001-07-03
IL97656A (en) 1996-06-18
AU632914B2 (en) 1993-01-14
FI98461B (fi) 1997-03-14
EP0449175A3 (en) 1993-01-20
NO911200D0 (no) 1991-03-25
DE69127010D1 (de) 1997-09-04
DK0449175T3 (da) 1998-02-23
JPH04221384A (ja) 1992-08-11
CA2038747C (en) 2002-05-28
FI98461C (fi) 1997-06-25
DE69127010T2 (de) 1997-11-13
US5047534A (en) 1991-09-10
FI911420A (fi) 1991-09-27
ZA912038B (en) 1991-12-24
NZ237484A (en) 1993-10-26
KR910016752A (ko) 1991-11-05

Similar Documents

Publication Publication Date Title
NO176759C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater
NO180749C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzimidazolsubstituerte derivater
ZA909141B (en) Therapeutically active chloro substituted benzimidazoles,processes for their preparation as well as their use
NL192986B (nl) Werkwijze voor het bereiden van 1,4-dihydro-4-oxo-naftyridinederivaten.
NO179908C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, carbocykliske adenosinanaloger
NO177591C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler
NO174959C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater
NO178967C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazin-derivater
NO176142C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aminoalkoksyfenylderivater
NO177096C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte isokinoliner
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
NO175781C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive tetracykliske forbindelser
KR950700252A (ko) 피브리노겐 수용체 길항제를 제조하는 방법(Process for preparing fibrinogen receptor antagonists)
NO176100C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive oksodihydropyridyl- og oksodihydropyridazinylkromanderivater
NO174200C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-imino-6-polyfluoralkoksybenzotiazol-forbindelser
FI98459B (fi) Menetelmä terapeuttisesti käyttökelpoisten 5-etano-2,3,4,5-1H-2-bentsatsepin-7-olikarbamaattijohdannaisten valmistamiseksi
NO174668C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7 tetranor-4,8-inter-m-fenylen PGI2 derivater
NO178624C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-substituerte alkyl-3-karboksy-karbapenemer
NO176242C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 5-substituerte ornithinderivater
NO176105C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidderivater
NO177099C (no) Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive steroidderivater
NO179367C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive fenoksy-heterocykliske forbindelser
FI910448A (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo/2,3b/indolijohdannaisten valmistamiseksi
DE69012388D1 (de) Selektive Adenosinrezeptor-Verbindungen.
NO174393C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-metyl-19-nor-pregna-4,6-diener som er 17 eventuelt 21-alkylert

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2003